Answers are grounded in this paper and cite their sources.
Preclinical study reveals extensive phase 1 metabolism of muvadenant across species, suggesting conserved metabolic pathways between preclinical models and humans.
incubations across species revealed extensive phase 1 metabolism of muvadenant with comparable metabolic pathways in human and preclinical species.
No takes yet. Share an insight, caveat, or question.
Nachtigall et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: